Lars Gedda

Real-time immunohistochemistry analysis of embedded tissue.

Karl Andersson, Lars Gedda, Hanna Björkelund, 2010, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

A New Antibody Recognizing the vIII Mutation of Human Epidermal Growth Factor Receptor

Rolf Larsson, Torgny Stigbrand, Kenneth Wester, 2002, Tumor Biology.

Avoiding false negative results in specificity analysis of protein–protein interactions

Karl Andersson, Lars Gedda, Hanna Björkelund, 2011, Journal of molecular recognition : JMR.

[177Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells

Vladimir Tolmachev, Mattias Sandström, Jörgen Carlsson, 2005, European Journal of Nuclear Medicine and Molecular Imaging.

Combining phage and staphylococcal surface display for generation of ErbB3-specific Affibody molecules.

Fredrik Y Frejd, John Löfblom, Martin Nilsson, 2011, Protein engineering, design & selection : PEDS.

Engineering and characterization of a bispecific HER2 × EGFR‐binding affibody molecule

Fredrik Y Frejd, Helene Andersson-Svahn, Sara Lindström, 2009, Biotechnology and applied biochemistry.

111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors.

Vladimir Tolmachev, Karl Andersson, Lars Gedda, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Blocking EGFR in the liver improves the tumor-to-liver uptake ratio of radiolabeled EGF

Matti Anniko, Hans Lundqvist, Lars Gedda, 2010, Tumor Biology.